One-pot magnetic separation of uranium (U) in seawater and groundwater samples has been made possible by synthesizing phosphoramidate functionalized Ag coated citrate-FeO nanoparticles (NPs). The magnetic saturation value of these functionalized NPs is 27.1 emu g. The synergistic extraction mechanism of U(VI) ion by the surface-modified phosphoramidate and citrate molecules make these NPs highly selective towards U(VI). The adsorption kinetics follows a pseudo-second-order model and the adsorption isotherm fits successfully to the Langmuir adsorption model. The functionalized NPs show quantitative extraction efficiency in the pH range of 6.5-8 with a maximum loading capacity (Q) of 108.7 mg g. The equilibration time required by these functionalized NPs to attain the Q value is 120 s. The recycling of these NPs can be done up to 5-6 times with 1.0 mol L of NaCO or NHOH for quantitative extraction of U(VI). These functionalized NPs show high resilience towards large number of naturally abundant metal ions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.talanta.2021.122372DOI Listing

Publication Analysis

Top Keywords

functionalized nps
16
magnetic separation
8
separation uranium
8
uranium seawater
8
seawater groundwater
8
phosphoramidate functionalized
8
quantitative extraction
8
nps
7
functionalized
6
rapid selective
4

Similar Publications

This study aims to use superparamagnetic iron oxide nanoparticles (SPIONs), specifically magnetite (FeO), to deliver deflazacort (DFZ) and ibuprofen (IBU) to Duchenne muscular dystrophy-affected (DMD) mouse muscles using an external magnetic field. The SPIONs are synthesized by the co-precipitation method, and their surfaces are functionalized with L-cysteine to anchor the drugs, considering that the cysteine on the surface of the SPIONs in the solid state dimerizes to form the cystine molecule, creating the FeO-(Cys)-DFZ and FeO-(Cys)-IBU systems for tests. The FeO nanoparticles (NPs) were characterized by Fourier transform infrared spectroscopy (FTIR), Raman spectroscopy, powder X-ray diffraction (PXRD), transmission electron microscopy (TEM), dynamic light scattering (DLS), and magnetic measurements.

View Article and Find Full Text PDF

In vitro metabolism of seven arolyl-derived fentanyl-type new psychoactive substances.

Arch Toxicol

January 2025

School of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, People's Republic of China.

Over the past decade, fentanyl-type new psychoactive substances (F-NPS) have emerged as the most representative synthetic opioids in third-generation drugs. These substances are characterized by their "low" fatal dose and parent drug levels in biological matrices, "fast" rates of derivatization and metabolism, and "many" derivatization sites and analogs. The low levels of parent fentanyl NPS in biological matrices complicate their detection, necessitating the use of characteristic metabolites as biomarkers for forensic analysis.

View Article and Find Full Text PDF

Background: Patients with Alzheimer's Disease (AD) frequently manifest comorbid neuropsychiatric symptoms (NPS) with depression and anxiety being most prevalent. Previously we identified shared genetic risk loci between AD and major depressive disorder (MDD). In another study, we constructed a polygenic risk score (PRS) based on MDD-GWAS data and demonstrated its performance in predicting depression onset in LOAD patients.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

G. H. Sergievsky Center, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.

Background: Neuropsychiatric Symptoms (NPS) (e.g., aggression, psychosis, anxiety, apathy, depression, agitation, sleep disturbances, repetitive behaviors) occur in 85% of AD patients, and are associated with accelerated decline, out-of-home placement, increased costs, and greatly increased suffering of patients and families.

View Article and Find Full Text PDF

Background: Clinicopathological studies suggest a role of minor cerebrovascular changes in the cognitive decline of individuals with a low neurodegenerative burden. However, it remains unclear whether small vascular brain lesions can impact cognition in middle aging individuals. Additionally, recent clinicopathological studies have shown that even a low Alzheimer's disease (AD) neuropathological burden can significantly impact neuropsychiatric function.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!